Association of Obesity with Cardiovascular Risk Factors and Kidney Disease Outcomes in Primary Proteinuric Glomerulopathies
Paras P. Shah(Northwell Health), Christine B. Sethna(Cohen Children's Medical Center), Brenda W. Gillespie(University of Michigan–Ann Arbor), Jarcy Zee(Children's Hospital of Philadelphia), Katherine R. Tuttle(Providence Regional Medical Center Everett), Markus Bitzer(Oregon Health & Science University), Chia-shi Wang(Emory University), Vimal K. Derebail(University of North Carolina at Chapel Hill), Dorey A. Glenn, Kevin Meyers(University of Pennsylvania), Tammy M. Brady(Johns Hopkins University), Tarak Srivastava, Daniel C. Cattran(Toronto Rehabilitation Institute), Keisha L. Gibson(University of North Carolina at Chapel Hill), Crystal A. Gadegbeku(Kidney Associates), Michelle M. O’Shaughnessy(Ollscoil na Gaillimhe – University of Galway)
Cited by 19
Related Papers
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
|Circulation|2023|1.7k
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
|New England Journal of Medicine|2024|1.5k
The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification
|Kidney International|2009|1.2k
Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group
|Kidney International|2017|1.2k